Tipsheet
What matters at India’s listed companies
Consumer Food · Mega cap

Marico's lead independent director retires, board fills gaps

Milind Barve cites persistent health issues for retirement effective August 1, 2026. Succession is immediate and orderly with Girish Paranjpe and Apurva Purohit taking over committee chairs.

2 earlier stories on Marico Ltd.
Mkt cap₹1.07 lakh cr
P/E60.85×
ROE40.99%
Debt / eq.0.10
Div yld0.49%
August 1, 2026 Effective date of Milind Barve's retirement

What's new

  • Milind Barve, Marico's Lead Independent Director, retires due to health issues.
  • Barve chaired Audit, Risk Management, and Stakeholders Relationship committees.
  • Board appoints Girish Paranjpe (Audit & Risk) and Apurva Purohit (Stakeholders) as successors.

Why this matters

Losing an experienced Lead Independent Director who chaired three key committees is a governance loss. But the board moved same-day to fill committee chairs from within, keeping oversight intact. No business disruption.

What we're watching

  • Whether Marico will appoint a new Lead Independent Director or leave the role vacant.
  • Any further board changes in the coming quarters.
  • Investor feedback on governance continuity at the next AGM.

The full read

Milind Barve, Marico's Lead Independent Director and chair of three key committees, is retiring on August 1, 2026, citing persistent health issues. The board acknowledged his July 1 letter and acted immediately: Girish Paranjpe takes over the Audit and Risk Management committees, Apurva Purohit chairs the Stakeholders Relationship Committee from the next day. For a large-cap consumer company, losing an experienced independent director is notable. But the orderly succession, all replacements drawn from the existing board, means no governance vacuum. The market is unlikely to react; this is health-driven, not strategic. The open question is whether Marico will name a new Lead Independent Director or leave the role open.

Questions answered

Why is Milind Barve retiring?
Barve cited persistent health issues in his letter to the board. The retirement is effective August 1, 2026.
What committees did Barve chair?
He chaired the Audit Committee, Risk Management Committee, and Stakeholders Relationship Committee, and also served as Lead Independent Director.
Who replaces Barve on these committees?
Girish Paranjpe will chair the Audit and Risk Management committees, and Apurva Purohit will chair the Stakeholders Relationship Committee, effective August 2, 2026.
Does this change affect Marico's business or strategy?
No. The move is a standard board succession due to health reasons. The board filled positions promptly with existing independent directors, so business continuity is unaffected.
Mentioned: Milind Barve · Girish Paranjpe · Apurva Purohit
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Marico Ltd.

FMCG
₹1.09 L cr
P/E 61.79×

Latest quarter · Mar 2026

Sales₹3,333 cr
Net profit₹408 cr
Op. margin+15.6%
EPS₹3.01

Strength & growth

Debt / equity0.10×
Current ratio2.06×
Sales CAGR+8.5%
EPS CAGR+9.1%
Financials via Tijori — a research aid, not investment advice.MARICO on Tijori
  1. 1 Jul 2026 · 1:16 PM IST Marico's lead independent director retires, board fills gaps
  2. 4d ago Marico's Q1 volume growth hits double digits, highest in quarters
  3. 41d ago Marico puts protein shampoo into a ₹10,000+ crore market